Pierre Morel, M.D.
After being Assistant in the Service des Maladies du Sang of the University Hospital of Lille for 3 years, Dr. Pierre Morel moved as Praticien Hospitalier in the Service d’Hematologie Clinique Jean Bernard of Lens in 1992. Since that time he has conducted in several trials, especially of the Groupe d’Etude des Lymphomes de l’Adulte and he has been involved in the data management of clinical and biological data. Most of his publications reported new prognostic indexes for myelodysplastic syndrome, follicular lymphoma , primary myelofibrosis, and Waldenstrom Macroglobulinemia, including the International scoring system for this disease developed with the collaboration of 7 institutions or cooperative groups.
Pierre Morel focuses now on the long-term prognostic effect of clinical, biological or treatment characteristics in patients with chronic disease, especially Waldenström macroglobulinemia, in the framework of the Centre d’Etude et de Recherche en Informatique Médicale (Lille).